|
Vol. 36 Nš 9 |
Lat. Am. J. Pharm. 36 (9): 1697-1908 (2017) |
REGULAR ARTICLES |
 |
|
Inhibiting Human Osteogenic Sarcoma Cell Growth In Vitro of Two Novel Pyran- Ketone Derivatives *
YANG G., & HE J. (1703)
|
|
|
|
Ursolic Acid: Inhibition of Renal Injury by Preventing Inflammatory and Fibrosis in GK Rats *
CHEN X., SHI Y., TU H., CHENG X., ZHANG H., ZHANG Y., LV Z., QI Y., & HAN S. (1709)
|
|
|
|
A Fast UPLC-MS/MS Method for the Quantitation of Darusentan in Rat Plasma: Application to a Pharmacokinetic Study *
ZHOU Q., ZHOU Y., CHEN X. & HU G. (1716)
|
|
|
|
Pharmacokinetics of Tramadol and its Metabolites Following Rectal Administration in Healthy Volunteers *
SHAKYA S.R., KAEWNOPPARAT N., PHADOONGSOMBUT N., REANMONGKOL W. & WIWATTANAWONGSA K. (1721)
|
|
|
|
Altered Metabolic Behavior of Derivatives of Herbal Compounds Used for Treatment of Carcinoma of Mouth *
RUAN F., DAI J., YAN Q. & LU Y. (1730)
|
|
|
|
Drug-Drug Interaction (DDI) Due to the Inhibition of Fusidic Acid *
SHI, Y. (1736)
|
|
|
|
Synthesis, Biological Evaluation and Docking Studies of (E)-3-Aryl-2-(3,4,5-trimethoxybenzoyl) Acrylonitrile Derivatives as Anticancer Agents *
WANG G., QIU J., CHEN M., XIAO X., CAO A. & LI L. (1739)
|
|
|
|
The Influence of Mucopolysaccharide Polysulfate (MPS) on the Activity of Carboxylesterases (CES) *
JIANG P. (1746)
|
|
|
|
Drug-Drug Interaction Related with the Clinical Application of Lung Cancer Treatment Drug *
FU G. & ZHANG Q. (1749)
|
|
|
|
Exposure of Bisphenol A (BPA) Derivatives Affect the Metabolic Elimination of Alzheimer's Diseases Treatment Drugs *
ZHU, G. (1753)
|
|
|
|
Antibacterial Effect of Flavonoid 2,4-cis-3,4-cis-3,4,5,8-Tetramethoxy-[1",2":6,7]- Furanoflavan Against Pseudomonas aeruginosa *
MEIRELES D.R.P., OLIVEIRA H.M.B.F., PIMENTA E.S., CRUZ R.M.C., FERNANDES L.M.D., GOUVEIA F.F.F., LIMA A.F., FILHO A.A.O. & LIMA E.O. (1760)
|
|
|
|
Drug-Drug Interactions in the Treatment of Ovarian Cancer *
HOU, L. (1765)
|
|
|
|
Regorafenib Disturbs the Metabolism of Ticagrelor Catalyzed by UDP-Glucuronosyltransferase (UGT) 2B7 *
SUN H., LIU G., CAO H., XIAO S., WANG Y. & WANG Q. (1769)
|
|
|
|
A Simplified, Highly Selective and Sensitive Method for Simultaneous Quantitation of Clevidipine and its Primary Metabolite H152/81 in Beagle Whole Blood by Liquid Chromatography-Tandem Mass Spectrometry: Application to a Preclinical Bioequivalence Study *
WANG Y., ZHAO L., YANG W., LI T., LI Q., SABI-MOUKA E.M.B., SUN L. & DING L. (1774)
|
|
|
|
Drug-drug Interaction in the Treatment of Gastrointestinal Tumors *
YANG, J. (1784)
|
|
|
|
Diazotized Curcumin Containing Sulfonamides: Synthesis, Characterization and Antibacterial Activities *
AHMED M., QADIR M.A., & SHAFIQ M.I. (1789)
|
|
|
|
Co-Administration Risk Between Regorafenib and Irinotecan During the Therapy of Lung Cancer Patients *
LI M., ZHANG X., SUN G., BAI Y. & LIU C. (1796)
|
|
|
|
Lung Cancer Therapeutic Drug Vismodegib Showed Inhibition Potential Towards UDPGlucuronosyltransferase (UGT) 1A9 *
ZHAI S. & LI W. (1801)
|
|
|
|
Liver Cancer Treatment Drug Irinotecan-Related Drug-Drug Interaction *
LIU Y., YU H. & WANG X. (1806)
|
|
|
|
Tumor Treatment Drugs-Related Drug-Drug Interaction (DDI) between Vismodegib and Irinotecan *
YU J., WANG G., JIANG Y., JIANG Y., CAO Q., ZHANG X. & HAN J. (1811)
|
|
|
|
Synthesis and Cytotoxicity of Tetrahydroisoquinoline Derivatives: Finding New Potential Anti-colorectal Cancer Drugs *
LU M., DONG D., & ZHOU X. (1816)
|
|
|
|
Protective Effects of Thevetiaflavone on H2O2-induced PC12 Cells Injury via Improving Oxidative Stress and Mitochondrial Dysfunction *
YAO H., ZHANG X., WEI G., WU W., DUAN J., LI Y., ZHANG C. & LIU Y. (1821)
|
|
|
|
Quantitative Determination of Brexpiprazole in Rat Plasma by UPLC-MS/MS and Application to a Pharmacokinetic Study *
ZHANG X., ZHAN Y., HU X., FANG P. & QIAN J. (1827)
|
|
|
|
Celastrol Inhibits Colorectal Cancer Cell Growth In Vivo by Regulation of miR-21 *
LU W., WANG K., ZHANG L., & PAN H. (1833)
|
|
|
|
Edaravone Affects the Activity of Bone Cancer Treatment Relevant Enzyme UDP-Glucuronosyltransferase (UGT) 1A1 *
DONG Z., MA H. & MA H. (1839)
|
|
|
|
Antitumor, Antioxidant and Chemical Constituents Identification of the Chloroform Extract of Wild Libyan Sonchus oleraceus *
ABD EL-AZIM M.H.M. & SELIM Y. (1843)
|
|
|
|
Behavior of Community Pharmacist of Buraydah city, Saudi Arabia, on Dispensing Antibiotics Without Prescription: A Cross-Sectional Study *
AL-HARBI T.F., AL-HARBI M., ASDAQ S.M.B. & AL-YAMANI M. (1849)
|
|
|
|
Investigation of the Inhibition of Nintedanib Towards the Activity of UDP-Glucuronosyltransferases (Ugts) Isoforms *
FENG X. & MA H. (1854)
|
|
|
|
Development and Validation of Analytical Methods for Telmisartan Quantification in Raw Material and in Tablets by UV-Spectrophotometer and HPLC *
BORBA P.A.A., CAVALLERI C., PEZZINI B.R. & STULZER H.K. (1858)
|
|
|
|
Beneficial Effect of Xanthohumol, a Prenylated Flavanoid, on 3-Nitropropionic Acid Induced Huntington's Disease in a Rat Model *
ZHANG J., LI P., & WANG X. (1867)
|
|
|
|
Development and Validation of a Method for the Simultaneous Analysis of Miconazole Nitrate and Hydrocortisone Acetate in Pharmaceutical Dosage Form by Ultraviolet Spectroscopy *
REHMAN M.H., NAUREEN H., ABBAS N. & KHURSHEED M. (1875)
|
|
|
|
Brain Metabolic Changes in Rats After Dextromethorphan *
WU Q., HU Q., SUN F., DONG Y., WANG Q., MA J., WANG X. & ZHOU Y. (1882)
|
|
|
|
Qualitative Evaluation of Over the Counter Medications among Undergraduate Students of Pharmacy *
SHAHNAZ S., ARAIN M.I., GHOTO M.A. & DAYO A. (1887)
|
|
|
|
Investigation on Regulation of Critical Hemodynamic Variables by Correlative Optimal Control Studies for Pharmacokinetic-Pharmacodynamic Model *
SOWPARNIKA G.C., THIRUMARIMURUGAN M., SIVAKUMAR V.M., SARANYA S.N. & VINOTH N. (1892)
|
|
|
|
Development, Validation and Pharmacokinetic Application of a Simple and Robust RPHPLC Method for Quantitation of Raloxifene in Rat Plasma *
MAHMOOD S., SENGUPTA P., MANDAL U.K., CHATTERJEE B. & TAHER M. (1901)
|
|
|
_________________
* English
** Portugûes
|
 |
|
ACTIONS ___ ___ _
Submit Article
Check Manuscript Status
Suscription
Free Sample Issue
STATISTICS ___ ___
JCR Impact Factor 2019:
0.240
Issues per year: 12
ISSN 0326 2383 (printed ed.)
ISSN 2362-3853 (on line ed.)
NEWSLETTER ___ ___
JOIN |
|